185 related articles for article (PubMed ID: 37958691)
41. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
Hasler G; Nugent AC; Carlson PJ; Carson RE; Geraci M; Drevets WC
Arch Gen Psychiatry; 2008 Oct; 65(10):1166-75. PubMed ID: 18838633
[TBL] [Abstract][Full Text] [Related]
42. Explore structural and functional brain changes in insomnia disorder: A PRISMA-compliant whole brain ALE meta-analysis for multimodal MRI.
Wu Y; Zhuang Y; Qi J
Medicine (Baltimore); 2020 Apr; 99(14):e19151. PubMed ID: 32243357
[TBL] [Abstract][Full Text] [Related]
43. High trait aggression in men is associated with low 5-HT levels, as indexed by 5-HT4 receptor binding.
da Cunha-Bang S; Mc Mahon B; Fisher PM; Jensen PS; Svarer C; Knudsen GM
Soc Cogn Affect Neurosci; 2016 Apr; 11(4):548-55. PubMed ID: 26772668
[TBL] [Abstract][Full Text] [Related]
44. Neural correlates of successful emotional episodic encoding and retrieval: An SDM meta-analysis of neuroimaging studies.
Dahlgren K; Ferris C; Hamann S
Neuropsychologia; 2020 Jun; 143():107495. PubMed ID: 32416099
[TBL] [Abstract][Full Text] [Related]
45. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Meyer PT; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM; Hinz R
Neuroimage; 2010 Apr; 50(3):984-93. PubMed ID: 20083209
[TBL] [Abstract][Full Text] [Related]
46. The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations.
Cho SS; Strafella AP; Duff-Canning S; Zurowski M; Vijverman AC; Bruno V; Aquino CC; Criaud M; Rusjan PM; Houle S; Fox SH
Mov Disord Clin Pract; 2017; 4(5):698-709. PubMed ID: 30363421
[TBL] [Abstract][Full Text] [Related]
47. Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging.
T L'Estrade E; Hansen HD; Erlandsson M; Ohlsson TG; Knudsen GM; Herth MM
ACS Chem Neurosci; 2018 Jun; 9(6):1226-1229. PubMed ID: 29763291
[TBL] [Abstract][Full Text] [Related]
48. Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder.
Kim JH; Joo YH; Son YD; Kim HK; Kim JH
Neuropsychiatr Dis Treat; 2022; 18():2041-2053. PubMed ID: 36124236
[TBL] [Abstract][Full Text] [Related]
49. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
[TBL] [Abstract][Full Text] [Related]
50. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
[TBL] [Abstract][Full Text] [Related]
51. Serotonin release measured in the human brain: a PET study with [
Erritzoe D; Ashok AH; Searle GE; Colasanti A; Turton S; Lewis Y; Huiban M; Moz S; Passchier J; Saleem A; Beaver J; Lingford-Hughes A; Nutt DJ; Howes OD; Gunn RN; Knudsen GM; Rabiner EA
Neuropsychopharmacology; 2020 Apr; 45(5):804-810. PubMed ID: 31715617
[TBL] [Abstract][Full Text] [Related]
52. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [
Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH
Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131
[TBL] [Abstract][Full Text] [Related]
53. No association between serotonin 5-HT 1A receptors and spirituality among patients with major depressive disorders or healthy volunteers.
Karlsson H; Hirvonen J; Salminen JK; Hietala J
Mol Psychiatry; 2011 Mar; 16(3):282-5. PubMed ID: 19935737
[TBL] [Abstract][Full Text] [Related]
54. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
[TBL] [Abstract][Full Text] [Related]
55. Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.
Peremans K; Audenaert K; Coopman F; Blanckaert P; Jacobs F; Otte A; Verschooten F; van Bree H; van Heeringen K; Mertens J; Slegers G; Dierckx R
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1538-46. PubMed ID: 14579095
[TBL] [Abstract][Full Text] [Related]
56. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
[TBL] [Abstract][Full Text] [Related]
57. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
Baldinger P; Höflich AS; Mitterhauser M; Hahn A; Rami-Mark C; Spies M; Wadsak W; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522403
[TBL] [Abstract][Full Text] [Related]
58. Cerebral 5-HT release correlates with [
Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
[TBL] [Abstract][Full Text] [Related]
59. Abnormal Regional Spontaneous Neural Activity and Functional Connectivity in Unmedicated Patients with Narcolepsy Type 1: A Resting-State fMRI Study.
Wu L; Zhan Q; Liu Q; Xie S; Tian S; Xie L; Wu W
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497558
[TBL] [Abstract][Full Text] [Related]
60. Increased Binding Potential of Brain Adenosine A
Hayashi S; Inaji M; Nariai T; Oda K; Sakata M; Toyohara J; Ishii K; Ishiwata K; Maehara T
J Neurotrauma; 2018 Jan; 35(1):25-31. PubMed ID: 28728462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
